NZS Capital Confident in Tyler Technologies' AI Resilience
Finance

NZS Capital Confident in Tyler Technologies' AI Resilience

authorBy Lisa Jing
DateJun 22, 2026
Read time3 min

In the first quarter of 2026, NZS Capital, a prominent investment management entity, expressed its continued conviction in Tyler Technologies (TYL), a leading provider of software solutions for the public sector. The firm's investor letter, despite revealing an overall negative return for its Growth Equity Strategy in Q1 2026, underscored the robust nature of Tyler Technologies' offerings against the backdrop of emerging artificial intelligence concerns. This stance is rooted in the belief that TYL's mission-critical administrative software for governmental bodies holds significant intrinsic value and is unlikely to be supplanted by AI-native solutions.

NZS Capital Affirms Tyler Technologies' Strategic Position Against AI Disruptions

In Q1 2026, the financial markets witnessed a notable underperformance of NZS Capital's Growth Equity Strategy, with a gross return of -8.75% and a net return of -8.91%, falling short of the Morningstar Global Target Market Exposure Index's -3.30%. This downturn was largely attributed to a general weakness in growth stocks and the firm's considerable exposure to the software sector. Information Technology, Financials, and Healthcare segments were identified as primary detractors from absolute returns, while materials and semiconductor sub-sectors provided some positive impact.

Amidst this challenging investment climate, NZS Capital revealed new additions to its portfolio, including an optionality position in Tyler Technologies, Inc. (NYSE: TYL). Tyler Technologies specializes in integrated software and technology solutions catering to the U.S. public sector, encompassing critical functions such as public administration, property assessment, tax management, court systems, and public safety. As of June 18, 2026, TYL shares were trading at $276.88, having experienced an 11.61% decline over the past month and a 51.41% loss over the preceding 52 weeks, bringing its market capitalization to $11.39 billion.

NZS Capital emphasized its conviction in Tyler Technologies' resilience to AI concerns. The firm argues that TYL's software serves as "mission-critical Systems of Record" (SoR), whose value extends far beyond its code. These systems represent a minuscule fraction of a customer's operational budget, yet are indispensable. Given the inherently risk-averse nature of municipal government clients, NZS Capital deems it highly improbable that these foundational systems would be replaced by "AI-native" startups lacking a proven track record. Instead, the firm posits that AI agents are more likely to interact with and enhance existing high-NZS SoR rather than displace them entirely. NZS Capital also highlighted that a significant portion—approximately 70%—of its software holdings are in vertical market software, serving specific industries rather than broad enterprises, which they believe carries lower "seat risk" from AI-driven labor displacement.

While NZS Capital expresses confidence in TYL, it's worth noting that Tyler Technologies was not among the "40 Most Popular Stocks Among Hedge Funds Heading Into 2026." Furthermore, some investment entities, such as the TCW Concentrated Large Cap Growth Fund, opted to divest their stakes in TYL during Q1 2026 due to worries about AI disruption. This divergence in opinion underscores the ongoing debate within the investment community regarding the long-term implications of AI on established technology companies.

The investment landscape is continually evolving, with artificial intelligence posing both opportunities and challenges across various sectors. NZS Capital's calculated bet on Tyler Technologies highlights a nuanced perspective on AI's impact, suggesting that not all established software will be vulnerable to disruption. Instead, mission-critical systems embedded within specific, risk-averse sectors like government administration may find themselves augmented, rather than replaced, by AI. This viewpoint encourages a deeper examination of how technological advancements truly integrate with existing infrastructures and societal functions, rather than assuming a universal disruptive force. For investors, this implies the importance of detailed sector analysis and understanding the specific dynamics that dictate a company's resilience in the face of transformative technologies.

More Articles
Finance
Market Dynamics: Flows, Fed, and the S&P 500's Technical Outlook
The market is currently driven by technical factors rather than fundamentals. Following a record options expiration, quarter-end pension selling and a July reallocation wave are expected. While the S&P 500's technical setup is strong, market breadth remains narrow. Strong retail demand and ETF inflows, along with record buyback authorizations, suggest robust activity. However, the recent shift in the Federal Reserve's stance, with an easing bias potentially removed, challenges the assumption of continuous dip-buying and could introduce volatility.
By David RubensteinJun 22, 2026
Finance
The Trade Desk: A Value Proposition Amidst Shifting Growth Dynamics
Once a high-flying growth stock, The Trade Desk has experienced a significant downturn, with its share price plummeting over 50% year-to-date. This article delves into the factors contributing to its recent performance, including a deceleration in revenue growth, and assesses whether its current valuation positions it as an attractive investment for those seeking value rather than rapid growth in the online advertising sector.
By Morgan HouselJun 22, 2026
Finance
Acadia Pharmaceuticals: A Strong Contender for Covered Call Strategies
Acadia Pharmaceuticals (ACAD) continues to be a robust candidate for covered call strategies, with its stock demonstrating a 20% increase since the last evaluation and maintaining a stable trading trajectory. The company's growth is primarily fueled by its key products, Nuplazid and DAYBUE, with the latter's full Q2 launch expected to further boost sales. Despite recent earnings and revenue shortfalls in Q1, ACAD remains profitable and well-capitalized, boasting $850 million in cash reserves and no long-term debt. Management has reaffirmed its revenue guidance of $1.22–$1.28 billion for fiscal year 2026, underscoring the company's solid financial health and potential for sustained option premiums.
By Lisa JingJun 22, 2026
Finance
GeneDx: A Deep Dive into a Potentially Undervalued Genomic Stock
GeneDx (WGS) shares have experienced a significant decline, dropping 65% since November. This downturn followed a guidance cut in Q1 2026. Despite this, the company demonstrates robust demand, with testing volume showing strong growth. The primary concern lies with reduced reimbursement rates due to a strategic shift towards genome testing, which has impacted revenue growth. However, GeneDx's extensive rare disease genomic database offers a unique competitive edge and considerable potential for AI-driven value creation. This analysis suggests the reimbursement issue is temporary, anticipating a rebound in rates and projecting a fair value of $85-90 per share by 2026.
By Morgan HouselJun 22, 2026
Finance
Navigating the Hawkish Fed: Opportunities in High-Yield Dividends
The Federal Reserve's recent hawkish stance has surprised many, shifting expectations towards earlier rate hikes. This uncertainty, particularly concerning interest-rate-sensitive assets, creates unique opportunities for astute high-yield investors. This article explores two dividend-paying gems with yields exceeding 12%, presenting enticing prospects for durable income without new inherent risks.
By Suze OrmanJun 22, 2026